Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfic
|
ENSMUSG00000055053.11 | nuclear factor I/C |
Nfib
|
ENSMUSG00000008575.11 | nuclear factor I/B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_82470336_82470487 | Nfib | 28905 | 0.165685 | 0.75 | 3.9e-11 | Click! |
chr4_82505419_82505978 | Nfib | 9 | 0.976439 | 0.66 | 5.7e-08 | Click! |
chr4_82506098_82506643 | Nfib | 591 | 0.698904 | 0.60 | 1.3e-06 | Click! |
chr4_82470694_82470845 | Nfib | 28547 | 0.166524 | 0.59 | 1.8e-06 | Click! |
chr4_82499267_82499620 | Nfib | 127 | 0.966812 | 0.57 | 5.5e-06 | Click! |
chr10_81426920_81427212 | Nfic | 48 | 0.922577 | 0.72 | 4.6e-10 | Click! |
chr10_81424847_81425044 | Nfic | 2169 | 0.112109 | 0.72 | 5.3e-10 | Click! |
chr10_81424626_81424804 | Nfic | 2399 | 0.103062 | 0.70 | 2.8e-09 | Click! |
chr10_81424278_81424578 | Nfic | 2686 | 0.094661 | 0.64 | 1.9e-07 | Click! |
chr10_81407387_81407940 | Nfic | 22 | 0.915520 | 0.60 | 1.4e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_73022390_73023322 | 61.16 |
Gm30420 |
predicted gene, 30420 |
6222 |
0.24 |
chr9_49976151_49976668 | 56.59 |
Gm47543 |
predicted gene, 47543 |
21531 |
0.25 |
chr12_71748739_71749094 | 55.96 |
Gm47555 |
predicted gene, 47555 |
5469 |
0.23 |
chr9_110684037_110684385 | 55.01 |
Gm35715 |
predicted gene, 35715 |
9257 |
0.11 |
chr9_30140175_30140600 | 51.16 |
Gm47677 |
predicted gene, 47677 |
27188 |
0.23 |
chr10_95117582_95117976 | 50.76 |
Gm48868 |
predicted gene, 48868 |
1400 |
0.39 |
chr15_49065913_49066220 | 47.58 |
Gm2333 |
predicted gene 2333 |
64898 |
0.13 |
chr10_94829375_94829721 | 47.17 |
Plxnc1 |
plexin C1 |
2 |
0.97 |
chr14_57607608_57607822 | 45.19 |
1700039M10Rik |
RIKEN cDNA 1700039M10 gene |
36101 |
0.11 |
chr8_123142100_123142497 | 44.47 |
Mir7080 |
microRNA 7080 |
12192 |
0.07 |
chr6_31011485_31011682 | 44.44 |
Mir29a |
microRNA 29a |
51164 |
0.08 |
chr1_133226926_133227325 | 44.14 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
18972 |
0.15 |
chr6_117254652_117255147 | 42.95 |
Rpl28-ps4 |
ribosomal protein L28, pseudogene 4 |
40833 |
0.16 |
chr10_13446842_13447237 | 42.68 |
Phactr2 |
phosphatase and actin regulator 2 |
27373 |
0.19 |
chr11_66998572_66998745 | 42.56 |
Gm12299 |
predicted gene 12299 |
3428 |
0.18 |
chr16_4273811_4274410 | 41.22 |
Gm5766 |
predicted gene 5766 |
43809 |
0.12 |
chr4_98563533_98563784 | 41.14 |
Gm22625 |
predicted gene, 22625 |
5793 |
0.22 |
chr3_104385623_104385970 | 41.10 |
Gm5546 |
predicted gene 5546 |
19183 |
0.13 |
chr1_132844199_132844367 | 41.00 |
Gm22609 |
predicted gene, 22609 |
29935 |
0.15 |
chr6_86599873_86600458 | 40.17 |
Gm44369 |
predicted gene, 44369 |
8735 |
0.11 |
chr1_118976609_118977117 | 40.15 |
Gli2 |
GLI-Kruppel family member GLI2 |
5725 |
0.24 |
chr13_91365084_91365800 | 38.67 |
Gm29540 |
predicted gene 29540 |
8852 |
0.21 |
chr2_150770681_150771163 | 38.49 |
Pygb |
brain glycogen phosphorylase |
15813 |
0.13 |
chr9_48760380_48760895 | 38.44 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
75308 |
0.1 |
chr3_89233602_89234072 | 38.03 |
Muc1 |
mucin 1, transmembrane |
2366 |
0.09 |
chr11_78929445_78929650 | 37.97 |
Nos2 |
nitric oxide synthase 2, inducible |
4371 |
0.22 |
chr8_114018414_114018750 | 37.46 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
114975 |
0.06 |
chr15_80707075_80707471 | 37.36 |
Tnrc6b |
trinucleotide repeat containing 6b |
4040 |
0.16 |
chr8_13530890_13531294 | 37.28 |
Gm5608 |
predicted gene 5608 |
15936 |
0.14 |
chr12_102307944_102308189 | 37.19 |
Rin3 |
Ras and Rab interactor 3 |
24425 |
0.19 |
chr14_60741580_60741814 | 36.79 |
Spata13 |
spermatogenesis associated 13 |
8791 |
0.19 |
chr5_133488147_133488307 | 36.75 |
Gm10051 |
predicted pseudogene 10051 |
13104 |
0.21 |
chr8_92972917_92973271 | 36.63 |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
12161 |
0.16 |
chr9_42799280_42799431 | 36.60 |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
9344 |
0.26 |
chr12_30244294_30244504 | 36.36 |
Sntg2 |
syntrophin, gamma 2 |
43064 |
0.18 |
chr7_130977605_130978173 | 36.26 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr4_129024792_129025193 | 35.59 |
Ak2 |
adenylate kinase 2 |
31639 |
0.11 |
chr5_77115099_77115353 | 35.14 |
Hopx |
HOP homeobox |
105 |
0.95 |
chr14_64350000_64350403 | 34.99 |
Msra |
methionine sulfoxide reductase A |
66747 |
0.12 |
chr8_26891964_26892147 | 34.98 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
7675 |
0.19 |
chr9_49989763_49990274 | 34.93 |
Gm47543 |
predicted gene, 47543 |
35140 |
0.21 |
chr2_28415593_28416061 | 34.81 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
30973 |
0.12 |
chr19_12475364_12475696 | 34.80 |
Mpeg1 |
macrophage expressed gene 1 |
14751 |
0.1 |
chr5_72855723_72856202 | 34.71 |
Tec |
tec protein tyrosine kinase |
11513 |
0.16 |
chr5_134014531_134015255 | 34.64 |
1700030N18Rik |
RIKEN cDNA 1700030N18 gene |
76558 |
0.08 |
chr5_122080969_122081260 | 34.50 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
19837 |
0.12 |
chr12_80366284_80366465 | 34.47 |
Dcaf5 |
DDB1 and CUL4 associated factor 5 |
10318 |
0.13 |
chr11_59283030_59283191 | 34.28 |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
7642 |
0.12 |
chr11_120261453_120262370 | 34.12 |
Gm47297 |
predicted gene, 47297 |
12576 |
0.1 |
chr5_129200262_129200420 | 34.03 |
Rps16-ps2 |
ribosomal protein S16, pseudogene 2 |
71824 |
0.1 |
chr14_59887444_59887846 | 34.03 |
Gm9013 |
predicted gene 9013 |
152846 |
0.04 |
chr5_138948065_138948968 | 33.66 |
Pdgfa |
platelet derived growth factor, alpha |
45765 |
0.12 |
chr1_73362046_73362544 | 33.64 |
D530049I02Rik |
RIKEN cDNA D530049I02 gene |
36673 |
0.15 |
chr13_43196003_43196529 | 33.58 |
Tbc1d7 |
TBC1 domain family, member 7 |
24765 |
0.19 |
chr17_31767233_31767462 | 33.31 |
Gm49999 |
predicted gene, 49999 |
22157 |
0.14 |
chr13_43134610_43134774 | 33.14 |
Phactr1 |
phosphatase and actin regulator 1 |
692 |
0.69 |
chr6_99934550_99934723 | 33.09 |
Gm44442 |
predicted gene, 44442 |
3087 |
0.25 |
chr1_152640519_152640989 | 33.04 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
15537 |
0.2 |
chr1_93210132_93210761 | 32.95 |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
25395 |
0.11 |
chr6_36818994_36819767 | 32.86 |
Ptn |
pleiotrophin |
9160 |
0.28 |
chr2_34531715_34532344 | 32.66 |
Gm13408 |
predicted gene 13408 |
32970 |
0.17 |
chr14_105830837_105830988 | 32.66 |
Gm22406 |
predicted gene, 22406 |
14004 |
0.21 |
chr12_15849972_15850142 | 32.59 |
Gm48558 |
predicted gene, 48558 |
568 |
0.72 |
chr8_44525992_44526276 | 32.53 |
Gm26241 |
predicted gene, 26241 |
21940 |
0.25 |
chr10_121837126_121837924 | 32.41 |
Gm48804 |
predicted gene, 48804 |
5467 |
0.22 |
chr12_82932669_82933345 | 32.17 |
1700085C21Rik |
RIKEN cDNA 1700085C21 gene |
6148 |
0.25 |
chr11_48568078_48568277 | 31.95 |
Gm12180 |
predicted gene 12180 |
178 |
0.95 |
chr4_107962144_107962358 | 31.81 |
Slc1a7 |
solute carrier family 1 (glutamate transporter), member 7 |
6081 |
0.14 |
chr6_49096972_49097479 | 31.73 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
3014 |
0.16 |
chr10_77464541_77465063 | 31.70 |
Gm35920 |
predicted gene, 35920 |
6885 |
0.17 |
chr10_41594987_41595356 | 31.69 |
Ccdc162 |
coiled-coil domain containing 162 |
7418 |
0.15 |
chr13_49178856_49179192 | 31.57 |
Ninj1 |
ninjurin 1 |
8461 |
0.18 |
chr7_4954113_4954364 | 31.56 |
Sbk2 |
SH3-binding domain kinase family, member 2 |
10107 |
0.07 |
chr2_27088066_27088247 | 31.51 |
Adamtsl2 |
ADAMTS-like 2 |
8777 |
0.12 |
chr13_92274593_92274854 | 31.48 |
Msh3 |
mutS homolog 3 |
8651 |
0.22 |
chr1_43694705_43695464 | 31.44 |
Ecrg4 |
ECRG4 augurin precursor |
35518 |
0.12 |
chr6_87282309_87282552 | 31.39 |
n-R5s164 |
nuclear encoded rRNA 5S 164 |
1281 |
0.31 |
chr5_123432150_123432381 | 31.36 |
Mlxip |
MLX interacting protein |
13774 |
0.08 |
chr15_32288555_32288748 | 31.27 |
Sema5a |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
43548 |
0.13 |
chr5_64045497_64045853 | 31.24 |
5830416I19Rik |
RIKEN cDNA 5830416I19 gene |
697 |
0.63 |
chr16_38625885_38626310 | 31.20 |
Tmem39a |
transmembrane protein 39a |
38058 |
0.11 |
chr1_54710668_54710827 | 31.19 |
Ankrd44 |
ankyrin repeat domain 44 |
12329 |
0.17 |
chr10_83805128_83805750 | 31.10 |
Gm47245 |
predicted gene, 47245 |
6126 |
0.26 |
chr4_13265110_13265483 | 31.05 |
Gm26250 |
predicted gene, 26250 |
1754 |
0.52 |
chr13_75752651_75752822 | 31.04 |
Ell2 |
elongation factor RNA polymerase II 2 |
2500 |
0.2 |
chr16_25407191_25407418 | 31.02 |
Gm18896 |
predicted gene, 18896 |
35969 |
0.22 |
chr11_68864733_68865246 | 30.96 |
Ndel1 |
nudE neurodevelopment protein 1 like 1 |
4 |
0.96 |
chr11_102339338_102339489 | 30.81 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
19671 |
0.09 |
chr16_4160633_4160799 | 30.79 |
Gm37186 |
predicted gene, 37186 |
12920 |
0.16 |
chr1_161233154_161233561 | 30.71 |
Prdx6 |
peroxiredoxin 6 |
17197 |
0.14 |
chr2_167989423_167989617 | 30.67 |
Ripor3 |
RIPOR family member 3 |
1827 |
0.3 |
chr2_180399642_180400133 | 30.51 |
Mir133a-2 |
microRNA 133a-2 |
1508 |
0.3 |
chr15_73242980_73243201 | 30.44 |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
74 |
0.97 |
chr16_6986105_6986416 | 30.34 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
83586 |
0.12 |
chr16_34456359_34456639 | 30.26 |
Kalrn |
kalirin, RhoGEF kinase |
418 |
0.91 |
chr11_68657873_68658156 | 30.17 |
Myh10 |
myosin, heavy polypeptide 10, non-muscle |
33545 |
0.15 |
chr14_60414775_60415004 | 30.07 |
Gm6066 |
predicted gene 6066 |
27090 |
0.17 |
chr8_84052805_84053051 | 29.89 |
Rln3 |
relaxin 3 |
7928 |
0.07 |
chr13_78483254_78483484 | 29.83 |
Gm32067 |
predicted gene, 32067 |
15 |
0.98 |
chr4_135653403_135653590 | 29.82 |
1700029M20Rik |
RIKEN cDNA 1700029M20 gene |
26243 |
0.12 |
chr12_4558721_4558885 | 29.78 |
Gm46332 |
predicted gene, 46332 |
5018 |
0.14 |
chr16_22494941_22495092 | 29.47 |
9230117E06Rik |
RIKEN cDNA 9230117E06 gene |
16464 |
0.12 |
chr14_8952976_8953147 | 29.41 |
Gm18071 |
predicted gene, 18071 |
26881 |
0.24 |
chr11_120255141_120255353 | 29.38 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
18548 |
0.09 |
chr15_101370123_101370813 | 29.15 |
Krt80 |
keratin 80 |
306 |
0.73 |
chr15_26673335_26673486 | 29.09 |
Gm49265 |
predicted gene, 49265 |
1343 |
0.41 |
chr11_74408965_74409169 | 29.08 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
1042 |
0.47 |
chr18_38578306_38578623 | 29.05 |
Gm19100 |
predicted gene, 19100 |
4386 |
0.19 |
chr16_14265466_14265813 | 29.04 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr1_73979335_73979549 | 29.02 |
Tns1 |
tensin 1 |
7621 |
0.24 |
chr9_56629715_56630294 | 29.00 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
5624 |
0.21 |
chr14_78383257_78383728 | 28.91 |
Gm26197 |
predicted gene, 26197 |
72152 |
0.09 |
chr11_64599216_64599501 | 28.91 |
Gm24275 |
predicted gene, 24275 |
8718 |
0.3 |
chr11_55016073_55016257 | 28.87 |
Anxa6 |
annexin A6 |
17250 |
0.15 |
chr3_89534810_89535019 | 28.79 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
14750 |
0.15 |
chr5_35138153_35138515 | 28.78 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
32568 |
0.16 |
chr17_27240609_27240802 | 28.72 |
9630028I04Rik |
RIKEN cDNA 9630028I04 gene |
1954 |
0.19 |
chr15_97750672_97750961 | 28.68 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
111 |
0.95 |
chr11_65475383_65475572 | 28.59 |
Gm12295 |
predicted gene 12295 |
109679 |
0.07 |
chr16_34924981_34925236 | 28.57 |
Mylk |
myosin, light polypeptide kinase |
5234 |
0.21 |
chr2_35513998_35514543 | 28.55 |
Gm35202 |
predicted gene, 35202 |
10739 |
0.13 |
chr17_49512714_49513028 | 28.54 |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
51435 |
0.13 |
chr9_49906473_49906652 | 28.50 |
Gm47543 |
predicted gene, 47543 |
48316 |
0.16 |
chr1_183680006_183680184 | 28.48 |
Gm8214 |
predicted gene 8214 |
2036 |
0.41 |
chr1_161494442_161494656 | 28.44 |
Tnfsf18 |
tumor necrosis factor (ligand) superfamily, member 18 |
106 |
0.97 |
chr16_5418938_5419089 | 28.33 |
n-R5s30 |
nuclear encoded rRNA 5S 30 |
94856 |
0.07 |
chr2_168019220_168019462 | 28.30 |
Ripor3 |
RIPOR family member 3 |
8723 |
0.15 |
chr1_170554940_170555198 | 28.25 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
2041 |
0.38 |
chr2_153475592_153476201 | 28.22 |
Nol4l |
nucleolar protein 4-like |
3830 |
0.22 |
chr2_126450539_126451010 | 28.20 |
Atp8b4 |
ATPase, class I, type 8B, member 4 |
40779 |
0.17 |
chr19_3353424_3354027 | 28.19 |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
12098 |
0.13 |
chr13_9314200_9314360 | 28.09 |
Gm48887 |
predicted gene, 48887 |
7147 |
0.13 |
chr13_44907872_44908308 | 28.05 |
Dtnbp1 |
dystrobrevin binding protein 1 |
39054 |
0.16 |
chr2_27217950_27218525 | 27.97 |
Sardh |
sarcosine dehydrogenase |
747 |
0.59 |
chr17_35812833_35813649 | 27.96 |
Ier3 |
immediate early response 3 |
8443 |
0.07 |
chr19_36687747_36688144 | 27.92 |
Hectd2os |
Hectd2, opposite strand |
1328 |
0.5 |
chr11_69891608_69891759 | 27.89 |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
1192 |
0.18 |
chr6_29388593_29389040 | 27.85 |
Opn1sw |
opsin 1 (cone pigments), short-wave-sensitive (color blindness, tritan) |
348 |
0.77 |
chr15_85669900_85671551 | 27.78 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr1_132851980_132852136 | 27.75 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
28215 |
0.15 |
chr7_109841931_109842298 | 27.75 |
Scube2 |
signal peptide, CUB domain, EGF-like 2 |
1187 |
0.43 |
chr9_21791954_21792245 | 27.67 |
Kank2 |
KN motif and ankyrin repeat domains 2 |
6404 |
0.11 |
chr11_33145846_33146490 | 27.66 |
Fgf18 |
fibroblast growth factor 18 |
627 |
0.67 |
chr10_68090256_68090550 | 27.65 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
46223 |
0.13 |
chr5_89701420_89702410 | 27.48 |
Gm25758 |
predicted gene, 25758 |
126956 |
0.05 |
chr17_43241232_43241481 | 27.48 |
Adgrf1 |
adhesion G protein-coupled receptor F1 |
28973 |
0.22 |
chr6_5992467_5992847 | 27.45 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
13409 |
0.22 |
chr8_35409283_35409464 | 27.38 |
Gm45301 |
predicted gene 45301 |
133 |
0.96 |
chr9_34993927_34994081 | 27.27 |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
22448 |
0.16 |
chr1_87879553_87880141 | 27.21 |
Dgkd |
diacylglycerol kinase, delta |
588 |
0.63 |
chr19_5940243_5940460 | 27.19 |
Pola2 |
polymerase (DNA directed), alpha 2 |
2368 |
0.13 |
chr11_50646254_50646436 | 27.16 |
Gm12198 |
predicted gene 12198 |
43897 |
0.12 |
chr18_84772004_84772338 | 27.08 |
Gm38576 |
predicted gene, 38576 |
28104 |
0.11 |
chr9_47358102_47358594 | 27.08 |
Gm31816 |
predicted gene, 31816 |
4402 |
0.31 |
chr17_85995802_85996008 | 27.06 |
Srbd1 |
S1 RNA binding domain 1 |
44459 |
0.17 |
chr8_13529970_13530351 | 26.99 |
Gm5608 |
predicted gene 5608 |
16868 |
0.14 |
chr12_86652768_86653097 | 26.98 |
Gm22004 |
predicted gene, 22004 |
2193 |
0.23 |
chr18_75223552_75223770 | 26.95 |
Gm8807 |
predicted gene 8807 |
40847 |
0.15 |
chr5_23518689_23519060 | 26.92 |
Kmt2e |
lysine (K)-specific methyltransferase 2E |
20605 |
0.16 |
chr15_72773133_72773360 | 26.87 |
Peg13 |
paternally expressed 13 |
37078 |
0.16 |
chrX_99872946_99873097 | 26.87 |
Tmem28 |
transmembrane protein 28 |
52000 |
0.15 |
chr10_3507849_3508237 | 26.83 |
Iyd |
iodotyrosine deiodinase |
32197 |
0.2 |
chr13_81103890_81104076 | 26.81 |
Gm18517 |
predicted gene, 18517 |
16419 |
0.15 |
chr8_33905789_33906327 | 26.72 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr2_27774078_27774756 | 26.70 |
Rxra |
retinoid X receptor alpha |
34216 |
0.19 |
chr11_97339033_97339195 | 26.67 |
Gpr179 |
G protein-coupled receptor 179 |
12902 |
0.12 |
chr5_35607873_35608051 | 26.63 |
Acox3 |
acyl-Coenzyme A oxidase 3, pristanoyl |
1003 |
0.47 |
chr12_84800461_84800617 | 26.53 |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
1076 |
0.45 |
chr2_153140280_153140471 | 26.53 |
Gm25643 |
predicted gene, 25643 |
14638 |
0.14 |
chr6_85366322_85366828 | 26.49 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
7989 |
0.15 |
chr11_20858852_20859410 | 26.48 |
Gm22807 |
predicted gene, 22807 |
11250 |
0.15 |
chr2_38460869_38461233 | 26.41 |
Gm25081 |
predicted gene, 25081 |
19287 |
0.12 |
chr9_44078996_44079373 | 26.35 |
Usp2 |
ubiquitin specific peptidase 2 |
5755 |
0.08 |
chr15_66745520_66745694 | 26.30 |
Gm17140 |
predicted gene 17140 |
1280 |
0.47 |
chr18_33510187_33510545 | 26.30 |
Gm10549 |
predicted gene 10549 |
44161 |
0.15 |
chr16_34334994_34335264 | 26.19 |
Kalrn |
kalirin, RhoGEF kinase |
26670 |
0.26 |
chr13_60421304_60421613 | 26.19 |
Gm35333 |
predicted gene, 35333 |
5740 |
0.22 |
chr16_15386240_15386530 | 26.18 |
Gm6031 |
predicted gene 6031 |
39766 |
0.16 |
chr15_83233833_83233990 | 26.16 |
A4galt |
alpha 1,4-galactosyltransferase |
17818 |
0.12 |
chr10_41934443_41935500 | 26.15 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr16_31290381_31290690 | 26.13 |
Gm49767 |
predicted gene, 49767 |
1361 |
0.26 |
chr11_97694774_97695667 | 26.13 |
Pcgf2 |
polycomb group ring finger 2 |
2811 |
0.11 |
chr3_98417386_98417689 | 26.10 |
Gm43190 |
predicted gene 43190 |
31439 |
0.11 |
chr17_27317601_27317788 | 26.06 |
Mir7214 |
microRNA 7214 |
599 |
0.46 |
chrX_98380347_98380514 | 26.04 |
Gm14811 |
predicted gene 14811 |
103360 |
0.07 |
chr16_94827069_94827617 | 26.03 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
29329 |
0.18 |
chr6_90945852_90946167 | 25.99 |
Ppp1r2-ps2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2, pseudogene 2 |
40190 |
0.13 |
chr6_90506860_90507250 | 25.99 |
Gm44236 |
predicted gene, 44236 |
6247 |
0.12 |
chr7_99217743_99218019 | 25.97 |
Gm45012 |
predicted gene 45012 |
15515 |
0.11 |
chr10_61920939_61921300 | 25.97 |
Gm5750 |
predicted gene 5750 |
38505 |
0.14 |
chr1_24226131_24226533 | 25.96 |
Col9a1 |
collagen, type IX, alpha 1 |
3185 |
0.33 |
chr10_122894520_122895070 | 25.90 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
573 |
0.8 |
chr2_52438057_52438292 | 25.83 |
A430018G15Rik |
RIKEN cDNA A430018G15 gene |
13162 |
0.17 |
chr6_86157306_86157479 | 25.79 |
Gm19596 |
predicted gene, 19596 |
10240 |
0.16 |
chr13_56163836_56164219 | 25.78 |
Gm25148 |
predicted gene, 25148 |
3573 |
0.19 |
chr2_27936671_27936822 | 25.76 |
2810430I11Rik |
RIKEN cDNA 2810430I11 gene |
49694 |
0.13 |
chr16_33580751_33581254 | 25.75 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
15560 |
0.25 |
chr11_62643129_62643684 | 25.70 |
Lrrc75a |
leucine rich repeat containing 75A |
4634 |
0.1 |
chr4_72384628_72385513 | 25.68 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr15_66984888_66985086 | 25.68 |
Ndrg1 |
N-myc downstream regulated gene 1 |
15347 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.0 | 78.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
20.9 | 62.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
20.2 | 60.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
15.9 | 47.8 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
14.6 | 29.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
14.1 | 42.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
14.0 | 42.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
12.3 | 36.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
12.2 | 36.6 | GO:0021564 | vagus nerve development(GO:0021564) |
11.8 | 59.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
11.5 | 46.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
10.9 | 32.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
10.8 | 32.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
10.4 | 41.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
10.4 | 41.5 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
10.1 | 30.3 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
10.1 | 30.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
9.9 | 29.8 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
9.9 | 19.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
9.7 | 48.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
9.4 | 37.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
9.4 | 46.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
9.2 | 27.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
9.1 | 45.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
9.0 | 9.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
8.9 | 62.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
8.9 | 26.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
8.6 | 34.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
8.6 | 42.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
8.5 | 16.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
8.4 | 25.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
8.3 | 83.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
8.3 | 49.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
8.2 | 57.2 | GO:0060482 | lobar bronchus development(GO:0060482) |
8.1 | 8.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
8.1 | 56.6 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
7.8 | 31.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
7.8 | 39.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
7.7 | 7.7 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
7.6 | 30.3 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
7.5 | 30.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
7.4 | 22.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
7.3 | 21.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
7.1 | 42.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
7.1 | 14.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
7.1 | 14.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
7.1 | 14.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
6.9 | 20.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
6.9 | 41.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
6.7 | 40.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
6.7 | 20.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
6.6 | 19.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.6 | 39.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
6.6 | 19.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
6.6 | 19.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
6.6 | 26.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.5 | 32.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
6.3 | 31.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
6.3 | 18.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
6.3 | 12.5 | GO:0003166 | bundle of His development(GO:0003166) |
6.2 | 31.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
6.2 | 37.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
6.2 | 30.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
6.2 | 18.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
6.1 | 36.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
6.1 | 18.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.9 | 17.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
5.8 | 17.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
5.7 | 22.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
5.7 | 17.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.7 | 56.7 | GO:0032060 | bleb assembly(GO:0032060) |
5.6 | 11.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
5.6 | 16.8 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
5.6 | 5.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
5.6 | 38.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
5.4 | 32.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
5.4 | 16.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
5.3 | 15.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
5.2 | 15.7 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
5.2 | 21.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
5.2 | 31.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
5.2 | 15.7 | GO:0007525 | somatic muscle development(GO:0007525) |
5.2 | 15.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
5.2 | 5.2 | GO:0001840 | neural plate development(GO:0001840) |
5.2 | 25.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
5.1 | 15.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
5.1 | 30.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
5.1 | 10.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
5.1 | 15.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
5.0 | 50.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
5.0 | 10.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
5.0 | 25.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
5.0 | 5.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
5.0 | 19.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
4.9 | 9.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
4.9 | 14.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
4.9 | 9.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
4.8 | 14.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
4.8 | 43.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
4.7 | 23.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
4.7 | 14.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
4.6 | 41.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
4.5 | 18.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.5 | 9.1 | GO:0003175 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
4.5 | 13.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
4.5 | 27.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
4.5 | 9.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
4.5 | 13.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
4.5 | 22.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
4.5 | 17.8 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
4.4 | 4.4 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
4.4 | 17.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
4.4 | 13.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
4.4 | 4.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.4 | 4.4 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
4.4 | 26.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.4 | 13.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
4.3 | 4.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
4.2 | 12.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
4.2 | 12.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
4.2 | 16.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
4.2 | 67.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
4.2 | 8.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
4.2 | 8.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
4.1 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.1 | 8.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.1 | 8.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
4.1 | 24.6 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
4.1 | 12.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
4.1 | 4.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
4.0 | 12.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
4.0 | 8.1 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
4.0 | 20.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
4.0 | 12.0 | GO:0001927 | exocyst assembly(GO:0001927) |
4.0 | 32.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
4.0 | 31.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
3.9 | 11.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.9 | 46.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
3.9 | 11.6 | GO:0032898 | neurotrophin production(GO:0032898) |
3.9 | 19.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.8 | 26.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
3.8 | 15.4 | GO:0015705 | iodide transport(GO:0015705) |
3.8 | 11.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
3.8 | 15.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
3.8 | 15.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
3.8 | 22.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.8 | 11.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.8 | 7.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.8 | 15.1 | GO:0048539 | bone marrow development(GO:0048539) |
3.8 | 18.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
3.8 | 18.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.8 | 22.6 | GO:0051775 | response to redox state(GO:0051775) |
3.8 | 7.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
3.7 | 3.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
3.7 | 14.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
3.7 | 3.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
3.7 | 14.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.7 | 7.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
3.7 | 3.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
3.6 | 10.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
3.6 | 32.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
3.6 | 10.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
3.6 | 3.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.6 | 10.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
3.6 | 10.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.5 | 3.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.5 | 10.6 | GO:0061042 | vascular wound healing(GO:0061042) |
3.5 | 14.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.5 | 3.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.5 | 3.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.5 | 13.9 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
3.5 | 10.4 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
3.5 | 20.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
3.4 | 13.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.4 | 13.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
3.4 | 10.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
3.4 | 13.7 | GO:0007296 | vitellogenesis(GO:0007296) |
3.4 | 17.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
3.4 | 6.7 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
3.4 | 13.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
3.4 | 6.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.4 | 3.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
3.3 | 6.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
3.3 | 13.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
3.3 | 19.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
3.3 | 9.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.3 | 167.8 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
3.3 | 3.3 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
3.3 | 9.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.3 | 22.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
3.3 | 9.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.3 | 9.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.2 | 19.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
3.2 | 13.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
3.2 | 9.7 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
3.2 | 6.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
3.2 | 25.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
3.2 | 3.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
3.2 | 12.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
3.2 | 3.2 | GO:0060437 | lung growth(GO:0060437) |
3.2 | 12.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
3.2 | 6.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
3.2 | 9.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
3.2 | 3.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
3.2 | 3.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
3.1 | 6.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
3.1 | 3.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
3.1 | 9.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.1 | 6.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
3.1 | 6.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
3.1 | 21.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.1 | 9.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
3.1 | 21.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
3.1 | 9.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.1 | 6.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
3.1 | 27.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
3.1 | 12.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
3.1 | 39.8 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
3.0 | 9.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
3.0 | 15.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
3.0 | 9.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
3.0 | 9.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.0 | 6.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
3.0 | 18.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
3.0 | 15.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
3.0 | 14.9 | GO:0006116 | NADH oxidation(GO:0006116) |
3.0 | 17.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
3.0 | 3.0 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
3.0 | 14.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.0 | 20.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
3.0 | 3.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
3.0 | 20.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.9 | 14.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.9 | 2.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.9 | 8.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.9 | 17.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
2.9 | 5.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
2.9 | 14.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.9 | 34.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
2.9 | 5.7 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.9 | 8.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.8 | 5.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.8 | 14.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.8 | 5.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.8 | 11.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
2.8 | 11.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.8 | 5.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.8 | 16.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
2.8 | 8.4 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
2.8 | 22.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
2.8 | 2.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.8 | 2.8 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
2.8 | 8.3 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
2.8 | 16.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
2.8 | 13.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
2.7 | 5.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
2.7 | 5.5 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
2.7 | 13.5 | GO:0019695 | choline metabolic process(GO:0019695) |
2.7 | 24.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.7 | 5.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.7 | 18.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.7 | 13.4 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
2.7 | 2.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.7 | 8.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.7 | 8.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.7 | 8.0 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
2.7 | 2.7 | GO:0097503 | sialylation(GO:0097503) |
2.6 | 15.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
2.6 | 10.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.6 | 23.7 | GO:0051014 | actin filament severing(GO:0051014) |
2.6 | 2.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.6 | 5.2 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
2.6 | 5.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.6 | 7.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.6 | 2.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
2.6 | 7.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.6 | 2.6 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
2.6 | 15.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
2.6 | 5.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
2.6 | 20.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
2.6 | 2.6 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
2.6 | 5.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
2.6 | 7.7 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
2.5 | 43.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
2.5 | 12.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
2.5 | 10.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.5 | 5.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
2.5 | 5.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.5 | 5.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.5 | 7.6 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.5 | 10.1 | GO:0030091 | protein repair(GO:0030091) |
2.5 | 15.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
2.5 | 7.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
2.5 | 5.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
2.5 | 17.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
2.5 | 9.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 2.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.4 | 2.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
2.4 | 7.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.4 | 17.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
2.4 | 14.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
2.4 | 4.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
2.4 | 4.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
2.4 | 9.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.4 | 2.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.4 | 2.4 | GO:0007494 | midgut development(GO:0007494) |
2.4 | 2.4 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
2.4 | 7.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
2.4 | 4.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
2.4 | 11.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.4 | 28.4 | GO:0014850 | response to muscle activity(GO:0014850) |
2.4 | 9.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
2.4 | 4.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.4 | 11.8 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
2.4 | 2.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
2.4 | 25.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
2.3 | 4.7 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.3 | 16.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.3 | 4.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.3 | 4.6 | GO:0032439 | endosome localization(GO:0032439) |
2.3 | 11.6 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
2.3 | 16.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.3 | 4.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.3 | 9.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
2.3 | 4.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
2.3 | 2.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.3 | 6.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.2 | 13.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.2 | 2.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
2.2 | 33.6 | GO:0071800 | podosome assembly(GO:0071800) |
2.2 | 13.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
2.2 | 31.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
2.2 | 8.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.2 | 2.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
2.2 | 26.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
2.2 | 4.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
2.2 | 15.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.2 | 11.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
2.2 | 2.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
2.2 | 2.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.2 | 6.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
2.2 | 10.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
2.2 | 10.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.2 | 4.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.2 | 13.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
2.2 | 4.4 | GO:0018158 | protein oxidation(GO:0018158) |
2.2 | 6.5 | GO:0002576 | platelet degranulation(GO:0002576) |
2.2 | 2.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.2 | 19.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
2.2 | 17.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
2.2 | 17.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.2 | 6.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
2.2 | 6.5 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
2.2 | 12.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.1 | 2.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
2.1 | 2.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
2.1 | 6.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.1 | 12.8 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
2.1 | 4.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.1 | 27.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.1 | 2.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.1 | 12.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
2.1 | 14.7 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
2.1 | 4.2 | GO:0033058 | directional locomotion(GO:0033058) |
2.1 | 6.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.1 | 2.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
2.1 | 4.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.1 | 2.1 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.1 | 6.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
2.1 | 6.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.1 | 20.7 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
2.1 | 6.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.1 | 8.3 | GO:0007350 | blastoderm segmentation(GO:0007350) |
2.1 | 18.6 | GO:0010665 | positive regulation of striated muscle cell apoptotic process(GO:0010663) regulation of cardiac muscle cell apoptotic process(GO:0010665) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
2.1 | 47.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
2.1 | 31.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
2.1 | 8.3 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
2.1 | 8.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
2.1 | 8.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
2.1 | 6.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.0 | 4.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
2.0 | 4.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
2.0 | 14.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
2.0 | 10.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.0 | 12.2 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
2.0 | 14.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
2.0 | 18.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
2.0 | 2.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.0 | 4.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
2.0 | 36.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.0 | 8.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.0 | 8.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
2.0 | 2.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.0 | 4.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.0 | 69.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
2.0 | 6.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.0 | 4.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
2.0 | 2.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.0 | 2.0 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.0 | 9.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
2.0 | 15.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
2.0 | 5.9 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
2.0 | 5.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
2.0 | 7.8 | GO:0051198 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
1.9 | 1.9 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
1.9 | 9.7 | GO:0046836 | glycolipid transport(GO:0046836) |
1.9 | 5.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.9 | 3.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.9 | 7.7 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
1.9 | 7.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.9 | 3.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.9 | 5.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.9 | 7.7 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
1.9 | 9.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.9 | 1.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.9 | 3.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.9 | 3.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.9 | 3.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.9 | 17.2 | GO:0030575 | nuclear body organization(GO:0030575) |
1.9 | 1.9 | GO:1902075 | cellular response to salt(GO:1902075) |
1.9 | 17.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.9 | 1.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.9 | 19.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.9 | 3.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.9 | 17.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.9 | 7.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.9 | 5.6 | GO:0016264 | gap junction assembly(GO:0016264) |
1.9 | 1.9 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
1.9 | 1.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.9 | 1.9 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.9 | 13.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.9 | 9.4 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
1.9 | 5.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.9 | 9.3 | GO:0080009 | mRNA methylation(GO:0080009) |
1.9 | 3.7 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.9 | 1.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.9 | 3.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.9 | 5.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.9 | 37.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.8 | 5.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.8 | 5.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 7.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.8 | 5.5 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.8 | 9.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.8 | 1.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.8 | 1.8 | GO:0006868 | glutamine transport(GO:0006868) |
1.8 | 3.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.8 | 5.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.8 | 7.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.8 | 3.7 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
1.8 | 12.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.8 | 9.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.8 | 1.8 | GO:0098792 | xenophagy(GO:0098792) |
1.8 | 5.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.8 | 3.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.8 | 3.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.8 | 5.4 | GO:0019532 | oxalate transport(GO:0019532) |
1.8 | 5.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.8 | 9.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.8 | 3.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.8 | 10.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.8 | 5.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.8 | 23.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
1.8 | 1.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.8 | 3.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.8 | 5.3 | GO:0032570 | response to progesterone(GO:0032570) |
1.8 | 3.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.8 | 12.4 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.8 | 7.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.8 | 31.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.8 | 3.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.8 | 1.8 | GO:0097484 | dendrite extension(GO:0097484) |
1.8 | 5.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.8 | 5.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
1.7 | 10.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.7 | 8.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.7 | 1.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.7 | 5.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
1.7 | 12.1 | GO:0016322 | neuron remodeling(GO:0016322) |
1.7 | 5.2 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
1.7 | 1.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.7 | 3.5 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.7 | 6.9 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.7 | 1.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.7 | 3.4 | GO:0014888 | striated muscle adaptation(GO:0014888) |
1.7 | 5.2 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
1.7 | 13.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.7 | 3.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
1.7 | 5.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.7 | 3.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.7 | 3.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.7 | 17.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.7 | 6.8 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.7 | 10.2 | GO:0032328 | alanine transport(GO:0032328) |
1.7 | 18.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
1.7 | 13.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.7 | 5.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.7 | 3.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.7 | 1.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.7 | 32.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
1.7 | 3.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.7 | 5.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.7 | 5.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.7 | 5.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.7 | 5.0 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
1.7 | 3.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.7 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.7 | 11.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.7 | 50.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.7 | 8.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.7 | 1.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.7 | 3.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.7 | 8.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.7 | 1.7 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.7 | 1.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.7 | 28.2 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
1.7 | 1.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.7 | 6.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.7 | 28.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.6 | 3.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
1.6 | 9.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.6 | 1.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.6 | 3.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.6 | 11.5 | GO:0070986 | left/right axis specification(GO:0070986) |
1.6 | 18.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.6 | 8.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.6 | 8.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.6 | 13.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.6 | 3.3 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
1.6 | 4.9 | GO:0032196 | transposition(GO:0032196) |
1.6 | 6.5 | GO:0060613 | fat pad development(GO:0060613) |
1.6 | 1.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.6 | 1.6 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.6 | 1.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.6 | 1.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.6 | 14.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.6 | 3.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
1.6 | 12.9 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
1.6 | 3.2 | GO:0003283 | atrial septum development(GO:0003283) |
1.6 | 4.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.6 | 3.2 | GO:1901725 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
1.6 | 3.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.6 | 28.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.6 | 3.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.6 | 3.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.6 | 17.5 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.6 | 1.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.6 | 6.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.6 | 1.6 | GO:0003163 | sinoatrial node development(GO:0003163) |
1.6 | 9.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.6 | 3.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.6 | 17.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.6 | 12.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.6 | 1.6 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
1.6 | 4.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.6 | 4.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.6 | 1.6 | GO:0015744 | succinate transport(GO:0015744) |
1.6 | 4.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.6 | 3.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.6 | 9.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.6 | 6.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
1.6 | 4.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.6 | 1.6 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.6 | 3.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.6 | 3.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.6 | 6.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.6 | 9.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.5 | 7.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.5 | 1.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 3.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.5 | 3.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.5 | 6.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.5 | 3.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.5 | 4.6 | GO:0006983 | ER overload response(GO:0006983) |
1.5 | 3.1 | GO:0015755 | fructose transport(GO:0015755) |
1.5 | 4.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.5 | 3.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.5 | 4.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.5 | 15.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
1.5 | 4.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.5 | 1.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
1.5 | 4.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.5 | 42.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.5 | 4.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.5 | 12.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.5 | 3.0 | GO:0007398 | ectoderm development(GO:0007398) |
1.5 | 4.6 | GO:0021603 | cranial nerve formation(GO:0021603) |
1.5 | 3.0 | GO:0001757 | somite specification(GO:0001757) |
1.5 | 1.5 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.5 | 3.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.5 | 3.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.5 | 4.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.5 | 4.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.5 | 4.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.5 | 4.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.5 | 5.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.5 | 2.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.5 | 11.7 | GO:0022038 | corpus callosum development(GO:0022038) |
1.5 | 19.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.5 | 1.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.5 | 2.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
1.4 | 30.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.4 | 11.5 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
1.4 | 7.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.4 | 7.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.4 | 12.9 | GO:0003334 | keratinocyte development(GO:0003334) |
1.4 | 4.3 | GO:0060914 | heart formation(GO:0060914) |
1.4 | 2.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.4 | 8.6 | GO:0015871 | choline transport(GO:0015871) |
1.4 | 11.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.4 | 28.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.4 | 1.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
1.4 | 11.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.4 | 2.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.4 | 4.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.4 | 2.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.4 | 2.8 | GO:0010288 | response to lead ion(GO:0010288) |
1.4 | 1.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.4 | 7.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
1.4 | 5.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.4 | 4.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.4 | 2.8 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.4 | 2.8 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.4 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.4 | 1.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
1.4 | 4.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.4 | 1.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.4 | 7.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
1.4 | 1.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.4 | 4.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.4 | 4.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.4 | 1.4 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.4 | 8.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.4 | 4.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.4 | 1.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.4 | 2.8 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
1.4 | 2.8 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
1.4 | 7.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.4 | 1.4 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
1.4 | 5.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.4 | 5.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.4 | 152.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
1.4 | 5.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.4 | 17.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
1.4 | 31.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 11.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.4 | 68.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
1.4 | 13.7 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
1.4 | 2.7 | GO:0061525 | hindgut development(GO:0061525) |
1.4 | 4.1 | GO:0018343 | protein farnesylation(GO:0018343) |
1.4 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.4 | 8.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
1.4 | 4.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.4 | 8.2 | GO:0072576 | liver morphogenesis(GO:0072576) |
1.4 | 2.7 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
1.4 | 2.7 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
1.4 | 2.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.4 | 1.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.4 | 1.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
1.4 | 8.1 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 2.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.4 | 9.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.4 | 1.4 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
1.4 | 2.7 | GO:0051451 | myoblast migration(GO:0051451) |
1.3 | 1.3 | GO:0033483 | gas homeostasis(GO:0033483) |
1.3 | 8.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.3 | 2.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
1.3 | 5.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.3 | 4.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.3 | 2.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.3 | 29.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
1.3 | 2.7 | GO:0032252 | secretory granule localization(GO:0032252) |
1.3 | 6.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.3 | 5.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 1.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.3 | 1.3 | GO:0010159 | specification of organ position(GO:0010159) |
1.3 | 4.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.3 | 26.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
1.3 | 1.3 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
1.3 | 4.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.3 | 4.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.3 | 2.6 | GO:0010470 | regulation of gastrulation(GO:0010470) |
1.3 | 2.6 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
1.3 | 1.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.3 | 9.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.3 | 9.2 | GO:0034311 | diol metabolic process(GO:0034311) |
1.3 | 1.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.3 | 9.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.3 | 13.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.3 | 2.6 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
1.3 | 1.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.3 | 3.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.3 | 9.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.3 | 16.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.3 | 3.9 | GO:0010155 | regulation of proton transport(GO:0010155) |
1.3 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.3 | 3.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
1.3 | 2.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.3 | 1.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.3 | 7.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.3 | 1.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 26.9 | GO:0010107 | potassium ion import(GO:0010107) |
1.3 | 2.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
1.3 | 3.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.3 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.3 | 6.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.3 | 5.0 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
1.3 | 1.3 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
1.3 | 2.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.2 | 1.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
1.2 | 2.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.2 | 2.5 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
1.2 | 22.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.2 | 1.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.2 | 4.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.2 | 1.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.2 | 4.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.2 | 3.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.2 | 23.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
1.2 | 18.5 | GO:0032400 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
1.2 | 6.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.2 | 7.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.2 | 2.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.2 | 4.9 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
1.2 | 19.5 | GO:0070527 | platelet aggregation(GO:0070527) |
1.2 | 1.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.2 | 4.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.2 | 6.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.2 | 1.2 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
1.2 | 36.4 | GO:0031424 | keratinization(GO:0031424) |
1.2 | 2.4 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.2 | 4.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.2 | 3.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.2 | 2.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.2 | 10.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.2 | 38.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.2 | 2.4 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
1.2 | 2.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.2 | 7.2 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
1.2 | 2.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.2 | 7.2 | GO:0050957 | equilibrioception(GO:0050957) |
1.2 | 16.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.2 | 7.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.2 | 2.4 | GO:0035483 | gastric emptying(GO:0035483) |
1.2 | 3.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.2 | 10.7 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
1.2 | 3.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
1.2 | 8.2 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.2 | 12.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
1.2 | 1.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.2 | 5.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.2 | 2.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
1.2 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.2 | 3.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.2 | 3.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
1.2 | 16.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
1.2 | 1.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
1.2 | 87.8 | GO:0030198 | extracellular matrix organization(GO:0030198) |
1.2 | 3.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.1 | 5.7 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.1 | 2.3 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.1 | 13.7 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.1 | 2.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
1.1 | 4.6 | GO:0035948 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.1 | 3.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.1 | 4.5 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
1.1 | 1.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
1.1 | 6.8 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.1 | 2.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
1.1 | 3.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.1 | 2.3 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
1.1 | 1.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.1 | 5.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.1 | 4.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
1.1 | 5.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.1 | 5.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.1 | 33.4 | GO:0007566 | embryo implantation(GO:0007566) |
1.1 | 4.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.1 | 5.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.1 | 1.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.1 | 21.0 | GO:0016180 | snRNA processing(GO:0016180) |
1.1 | 1.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
1.1 | 3.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.1 | 1.1 | GO:0007619 | courtship behavior(GO:0007619) |
1.1 | 3.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.1 | 2.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.1 | 4.4 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.1 | 8.8 | GO:0008272 | sulfate transport(GO:0008272) |
1.1 | 9.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
1.1 | 4.4 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
1.1 | 1.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.1 | 5.5 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
1.1 | 1.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 7.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.1 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.1 | 1.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.1 | 10.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.1 | 1.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.1 | 4.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
1.1 | 2.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.1 | 5.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
1.1 | 9.7 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
1.1 | 2.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 1.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.1 | 2.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.1 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 3.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.1 | 2.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.1 | 1.1 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
1.1 | 2.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.1 | 8.5 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.1 | 2.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
1.1 | 2.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.1 | 18.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.1 | 1.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.1 | 19.1 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
1.1 | 11.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
1.1 | 2.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.1 | 2.1 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
1.1 | 3.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 4.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.1 | 3.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.1 | 3.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
1.1 | 5.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.1 | 7.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.1 | 12.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.0 | 2.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.0 | 18.9 | GO:0030431 | sleep(GO:0030431) |
1.0 | 2.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
1.0 | 7.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.0 | 2.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.0 | 15.6 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
1.0 | 2.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.0 | 1.0 | GO:0002339 | B cell selection(GO:0002339) |
1.0 | 1.0 | GO:0071635 | negative regulation of transforming growth factor beta1 production(GO:0032911) negative regulation of transforming growth factor beta production(GO:0071635) |
1.0 | 4.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.0 | 1.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.0 | 2.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
1.0 | 11.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
1.0 | 5.2 | GO:0007281 | germ cell development(GO:0007281) |
1.0 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.0 | 4.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
1.0 | 1.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.0 | 8.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.0 | 3.1 | GO:0015888 | thiamine transport(GO:0015888) |
1.0 | 10.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.0 | 2.0 | GO:0060290 | transdifferentiation(GO:0060290) |
1.0 | 5.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
1.0 | 1.0 | GO:0015819 | lysine transport(GO:0015819) |
1.0 | 4.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
1.0 | 1.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.0 | 5.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.0 | 5.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.0 | 20.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.0 | 4.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.0 | 4.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
1.0 | 3.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.0 | 6.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.0 | 1.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.0 | 6.0 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 2.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.0 | 17.9 | GO:0097581 | lamellipodium organization(GO:0097581) |
1.0 | 2.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.0 | 4.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.0 | 3.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 19.8 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
1.0 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 3.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 1.0 | GO:0060068 | vagina development(GO:0060068) |
1.0 | 3.0 | GO:0007097 | nuclear migration(GO:0007097) |
1.0 | 2.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.0 | 4.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
1.0 | 61.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.0 | 2.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.0 | 10.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.0 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.0 | 15.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.0 | 8.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 2.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.0 | 1.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
1.0 | 12.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.0 | 2.9 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.0 | 1.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.0 | 4.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.0 | 2.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 2.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.0 | 1.0 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
1.0 | 3.8 | GO:0046697 | decidualization(GO:0046697) |
1.0 | 5.7 | GO:0001832 | blastocyst growth(GO:0001832) |
1.0 | 2.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 0.9 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.9 | 41.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.9 | 12.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.9 | 1.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.9 | 4.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.9 | 4.7 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.9 | 1.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.9 | 2.8 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.9 | 4.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.9 | 5.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.9 | 2.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 4.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.9 | 4.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.9 | 7.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.9 | 19.6 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.9 | 5.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.9 | 3.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.9 | 1.9 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.9 | 1.9 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.9 | 1.8 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.9 | 12.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.9 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.9 | 11.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.9 | 1.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.9 | 1.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.9 | 8.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.9 | 30.1 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.9 | 0.9 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.9 | 13.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.9 | 2.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.9 | 4.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.9 | 0.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.9 | 1.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 12.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.9 | 1.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.9 | 2.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.9 | 1.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.9 | 4.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.9 | 3.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.9 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.9 | 1.8 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.9 | 3.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.9 | 1.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.9 | 20.2 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.9 | 1.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.9 | 9.6 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.9 | 12.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.9 | 3.5 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 2.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.9 | 1.7 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.9 | 0.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 5.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.9 | 4.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.9 | 2.6 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.9 | 4.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.9 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.9 | 1.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.9 | 2.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.8 | 3.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 1.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 4.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.8 | 0.8 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.8 | 5.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.8 | 5.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.8 | 4.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.8 | 2.5 | GO:0071025 | RNA surveillance(GO:0071025) |
0.8 | 4.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.8 | 0.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.8 | 1.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.8 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 8.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.8 | 11.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.8 | 0.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.8 | 3.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.8 | 0.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 2.5 | GO:0060746 | parental behavior(GO:0060746) |
0.8 | 13.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.8 | 25.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.8 | 4.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 0.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.8 | 2.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.8 | 0.8 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.8 | 3.3 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.8 | 2.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 1.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 8.9 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.8 | 2.4 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 21.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.8 | 2.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.8 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 5.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 13.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.8 | 0.8 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.8 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 3.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.8 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.8 | 2.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.8 | 0.8 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.8 | 3.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.8 | 4.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.8 | 1.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.8 | 7.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.8 | 5.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.8 | 1.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.8 | 3.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.8 | 4.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.8 | 1.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.8 | 5.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.8 | 41.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.8 | 1.6 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.8 | 6.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.8 | 2.3 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.8 | 0.8 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.8 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.8 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.8 | 16.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.8 | 3.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 5.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 3.9 | GO:0009268 | response to pH(GO:0009268) |
0.8 | 1.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.8 | 5.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.8 | 2.3 | GO:0010224 | response to UV-B(GO:0010224) |
0.8 | 1.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.8 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.8 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 4.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.8 | 10.0 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.8 | 6.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 3.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.8 | 7.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.8 | 3.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.8 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.8 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.8 | 3.8 | GO:0009584 | detection of visible light(GO:0009584) |
0.8 | 2.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.8 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.7 | 2.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 2.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.7 | 3.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.7 | 1.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.7 | 3.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.7 | 4.5 | GO:0036065 | fucosylation(GO:0036065) |
0.7 | 1.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 2.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.7 | 2.2 | GO:1904357 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.7 | 7.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.7 | 9.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.7 | 5.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.7 | 1.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.7 | 1.5 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.7 | 12.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.7 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 1.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 3.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.7 | 8.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.7 | 1.5 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.7 | 3.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.7 | 3.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.7 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.7 | 1.4 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.7 | 2.9 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.7 | 0.7 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 10.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 2.9 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.7 | 1.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.7 | 5.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 5.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.7 | 6.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.7 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 2.1 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.7 | 0.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.7 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.7 | 0.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.7 | 1.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.7 | 0.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.7 | 4.2 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.7 | 2.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 2.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.7 | 0.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.7 | 2.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 13.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.7 | 13.9 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.7 | 0.7 | GO:0051608 | histamine transport(GO:0051608) |
0.7 | 15.9 | GO:0009408 | response to heat(GO:0009408) |
0.7 | 0.7 | GO:0031641 | regulation of myelination(GO:0031641) |
0.7 | 1.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.7 | 6.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.7 | 0.7 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.7 | 4.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.7 | 3.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.7 | 2.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.7 | GO:0048678 | response to axon injury(GO:0048678) |
0.7 | 2.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 6.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 2.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.7 | 2.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 1.3 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.7 | 2.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 15.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.7 | 1.3 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.7 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.7 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.7 | 0.7 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.7 | 2.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.7 | 5.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.7 | 2.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.7 | 4.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.7 | 0.7 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) |
0.7 | 1.3 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.7 | 3.3 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 5.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.6 | 1.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.6 | 3.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.6 | 3.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.6 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 14.8 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.6 | 10.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 1.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 19.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.6 | 1.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.6 | 1.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.6 | 1.9 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.6 | 6.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.6 | 7.7 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.6 | 0.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.6 | 0.6 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.6 | 1.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 1.9 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 2.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 5.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 17.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.6 | 0.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.6 | 7.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.6 | 0.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.6 | 1.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.6 | 1.9 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.6 | 0.6 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.6 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 13.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.6 | 1.9 | GO:0010738 | protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
0.6 | 3.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 6.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.6 | 1.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.6 | 2.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.6 | 0.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.6 | 0.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.6 | 2.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.6 | 1.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 0.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.6 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.6 | 4.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.6 | 1.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.6 | 90.1 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.6 | 1.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 1.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.6 | 0.6 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.6 | 1.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.6 | 0.6 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.6 | 4.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.6 | 6.6 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.6 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.6 | 15.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.6 | 3.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.6 | 3.6 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.6 | 10.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.6 | 0.6 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.6 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 1.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 2.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 3.5 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.6 | 1.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.6 | 1.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.6 | 0.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.6 | 1.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 1.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.6 | 1.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 6.4 | GO:0048265 | response to pain(GO:0048265) |
0.6 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 2.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.6 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 13.2 | GO:0048864 | stem cell development(GO:0048864) |
0.6 | 3.4 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.6 | 1.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 6.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.6 | 2.8 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.6 | 2.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.6 | 2.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.6 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.6 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 2.2 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.6 | 1.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.6 | 1.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.6 | 2.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 1.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.6 | 0.6 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 0.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.6 | 1.7 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 2.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.6 | 2.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 1.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.6 | 1.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.5 | 2.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.5 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.5 | 1.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 2.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 1.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.5 | 3.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 0.5 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.5 | 2.7 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.5 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.5 | 2.1 | GO:0003014 | renal system process(GO:0003014) |
0.5 | 10.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.5 | 2.7 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.5 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 0.5 | GO:0003300 | cardiac muscle hypertrophy(GO:0003300) |
0.5 | 3.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 7.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.5 | 2.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.5 | 6.3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.5 | 0.5 | GO:0051133 | regulation of NK T cell activation(GO:0051133) |
0.5 | 0.5 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.5 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.5 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 1.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.5 | 1.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 2.1 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.5 | 1.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 5.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 3.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 1.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.5 | 2.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.5 | 0.5 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.5 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 1.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.5 | 1.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.5 | 1.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 3.0 | GO:0001556 | oocyte maturation(GO:0001556) |
0.5 | 0.5 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.5 | 4.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.5 | 3.5 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.5 | 4.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.5 | 2.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 6.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.5 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 3.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.5 | 0.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 7.4 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.5 | 0.5 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.5 | 1.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 5.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.5 | 13.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.5 | 5.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 6.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.5 | 1.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 6.3 | GO:0090132 | epithelium migration(GO:0090132) |
0.5 | 1.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.5 | 1.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.5 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 0.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.5 | 3.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 35.0 | GO:0006457 | protein folding(GO:0006457) |
0.5 | 1.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 1.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 1.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 2.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.5 | 0.5 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.5 | 0.9 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.5 | 3.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.5 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 1.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.5 | 1.4 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.5 | 9.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.5 | 5.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.5 | 1.4 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.5 | 5.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.5 | 1.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.5 | 1.8 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
0.5 | 0.9 | GO:0035904 | aorta development(GO:0035904) |
0.5 | 1.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 1.8 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.5 | 0.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.5 | 1.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 2.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.5 | 0.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 0.4 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.4 | 3.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 1.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 1.3 | GO:0033198 | response to ATP(GO:0033198) |
0.4 | 12.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.8 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.4 | 11.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.4 | 0.9 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.4 | 3.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 6.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 3.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 0.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 0.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 1.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.4 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) negative regulation of glial cell proliferation(GO:0060253) |
0.4 | 3.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 1.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.4 | 3.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 2.1 | GO:0001656 | metanephros development(GO:0001656) |
0.4 | 0.4 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.4 | 0.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 2.9 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.4 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 5.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 2.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.4 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 1.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 2.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 0.4 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.4 | 0.8 | GO:0042701 | progesterone secretion(GO:0042701) |
0.4 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 0.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 1.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 1.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.4 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 2.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 25.4 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.4 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 6.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.4 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.9 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 2.3 | GO:0001825 | blastocyst formation(GO:0001825) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.8 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 2.3 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.4 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 3.8 | GO:0021782 | glial cell development(GO:0021782) |
0.4 | 1.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 0.4 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.4 | 2.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.4 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.4 | 6.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.4 | 8.5 | GO:0048477 | oogenesis(GO:0048477) |
0.4 | 4.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 2.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 8.8 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.4 | 4.0 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.4 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 0.7 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 1.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 0.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.4 | 0.4 | GO:0060324 | face development(GO:0060324) |
0.4 | 1.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.4 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.4 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.4 | 1.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.3 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 2.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 0.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.3 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 4.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 2.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 6.1 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.3 | 6.1 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 1.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.3 | GO:2000736 | regulation of stem cell differentiation(GO:2000736) |
0.3 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 4.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.3 | 3.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 2.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 6.0 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.3 | 1.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 5.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.3 | 0.3 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.3 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 3.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.3 | 2.8 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.3 | 1.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 11.8 | GO:0015992 | proton transport(GO:0015992) |
0.3 | 6.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.9 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.3 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.3 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 2.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 3.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.3 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 0.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 0.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.3 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.3 | 0.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 4.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.8 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 3.9 | GO:0014013 | regulation of gliogenesis(GO:0014013) |
0.3 | 1.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 8.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 1.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 4.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.3 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 2.7 | GO:0048738 | cardiac muscle tissue development(GO:0048738) |
0.3 | 0.3 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.3 | 0.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.3 | 1.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 0.8 | GO:0017145 | stem cell division(GO:0017145) |
0.3 | 2.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.5 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.3 | 2.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 1.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 0.8 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.3 | 3.3 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.3 | 1.8 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.3 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.3 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.3 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 6.0 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.2 | 1.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.2 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 5.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 0.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.2 | 5.4 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.2 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 1.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.9 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.2 | 1.2 | GO:0032094 | response to food(GO:0032094) |
0.2 | 1.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:0060840 | artery development(GO:0060840) |
0.2 | 3.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.5 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.2 | 0.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.2 | 17.9 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.2 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 5.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 2.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.9 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 0.2 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.2 | 8.5 | GO:0007507 | heart development(GO:0007507) |
0.2 | 0.9 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.9 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.2 | 31.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.2 | 2.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 0.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.2 | 7.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.4 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.2 | 0.2 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.2 | 1.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.2 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 12.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 0.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 5.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 0.2 | GO:0010637 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.7 | GO:0051899 | membrane depolarization(GO:0051899) |
0.2 | 0.5 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.2 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 1.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.5 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.2 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 14.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 0.3 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.2 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.2 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 10.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 1.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 1.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 2.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 2.2 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 0.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.8 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
0.1 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.8 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 3.0 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.1 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.2 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 1.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.6 | GO:0048736 | appendage development(GO:0048736) limb development(GO:0060173) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 12.0 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.1 | GO:0071709 | membrane assembly(GO:0071709) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.1 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.1 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.1 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 8.6 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.0 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 1.3 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.1 | 0.1 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 2.2 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.2 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 1.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 1.5 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 3.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.1 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.6 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.9 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 2.1 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.5 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.0 | 0.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.0 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 1.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.2 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 4.6 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.2 | 54.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
14.8 | 44.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
11.7 | 35.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
11.2 | 44.8 | GO:0071953 | elastic fiber(GO:0071953) |
11.0 | 98.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
8.7 | 26.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
8.3 | 66.2 | GO:0005861 | troponin complex(GO:0005861) |
8.2 | 32.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
7.7 | 23.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
7.5 | 22.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
6.8 | 20.3 | GO:0097443 | sorting endosome(GO:0097443) |
6.7 | 40.1 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
6.3 | 38.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
5.9 | 11.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
5.5 | 11.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
5.4 | 16.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
5.4 | 32.4 | GO:0005915 | zonula adherens(GO:0005915) |
5.4 | 21.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
5.3 | 48.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
5.3 | 21.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
5.1 | 40.5 | GO:0001520 | outer dense fiber(GO:0001520) |
5.1 | 45.5 | GO:0097470 | ribbon synapse(GO:0097470) |
4.9 | 38.9 | GO:0016342 | catenin complex(GO:0016342) |
4.8 | 48.0 | GO:0005916 | fascia adherens(GO:0005916) |
4.8 | 47.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
4.7 | 14.0 | GO:0044393 | microspike(GO:0044393) |
4.6 | 9.2 | GO:0097513 | myosin II filament(GO:0097513) |
4.4 | 22.0 | GO:0030056 | hemidesmosome(GO:0030056) |
4.3 | 17.2 | GO:0035363 | histone locus body(GO:0035363) |
4.2 | 50.7 | GO:0002102 | podosome(GO:0002102) |
4.2 | 205.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
4.2 | 25.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
4.1 | 12.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
4.0 | 16.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
3.8 | 64.9 | GO:0005614 | interstitial matrix(GO:0005614) |
3.8 | 11.3 | GO:1990393 | 3M complex(GO:1990393) |
3.7 | 15.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
3.7 | 14.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
3.7 | 3.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
3.7 | 11.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
3.6 | 28.9 | GO:0042587 | glycogen granule(GO:0042587) |
3.6 | 10.7 | GO:0030478 | actin cap(GO:0030478) |
3.6 | 3.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.5 | 10.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
3.5 | 10.4 | GO:0000322 | storage vacuole(GO:0000322) |
3.4 | 30.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
3.2 | 28.8 | GO:0097542 | ciliary tip(GO:0097542) |
3.2 | 9.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.1 | 18.8 | GO:0032982 | myosin filament(GO:0032982) |
3.1 | 3.1 | GO:0000125 | PCAF complex(GO:0000125) |
3.0 | 8.9 | GO:0043293 | apoptosome(GO:0043293) |
2.9 | 8.8 | GO:1990635 | proximal dendrite(GO:1990635) |
2.9 | 2.9 | GO:0032994 | protein-lipid complex(GO:0032994) |
2.9 | 32.1 | GO:0043034 | costamere(GO:0043034) |
2.9 | 2.9 | GO:0030684 | preribosome(GO:0030684) |
2.8 | 19.8 | GO:0033263 | CORVET complex(GO:0033263) |
2.8 | 11.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.8 | 5.6 | GO:0032432 | actin filament bundle(GO:0032432) |
2.8 | 2.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.8 | 11.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.7 | 43.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
2.7 | 13.5 | GO:0045180 | basal cortex(GO:0045180) |
2.6 | 31.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.6 | 68.1 | GO:0031672 | A band(GO:0031672) |
2.6 | 13.0 | GO:0042629 | mast cell granule(GO:0042629) |
2.6 | 31.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.6 | 7.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.5 | 2.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
2.5 | 711.1 | GO:0005925 | focal adhesion(GO:0005925) |
2.5 | 10.0 | GO:0044308 | axonal spine(GO:0044308) |
2.5 | 15.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.5 | 27.6 | GO:0036038 | MKS complex(GO:0036038) |
2.4 | 9.6 | GO:0005796 | Golgi lumen(GO:0005796) |
2.4 | 14.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.4 | 9.5 | GO:1990246 | uniplex complex(GO:1990246) |
2.4 | 9.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.4 | 7.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.4 | 16.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.4 | 4.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.3 | 9.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
2.3 | 25.3 | GO:0031528 | microvillus membrane(GO:0031528) |
2.3 | 9.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.3 | 114.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
2.3 | 2.3 | GO:0043219 | lateral loop(GO:0043219) |
2.2 | 6.7 | GO:0044299 | C-fiber(GO:0044299) |
2.2 | 15.5 | GO:0099738 | cell cortex region(GO:0099738) |
2.2 | 6.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.2 | 683.8 | GO:0031012 | extracellular matrix(GO:0031012) |
2.2 | 6.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.1 | 23.5 | GO:0035102 | PRC1 complex(GO:0035102) |
2.1 | 25.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
2.1 | 23.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.1 | 12.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.1 | 2.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.1 | 10.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.1 | 2.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
2.1 | 22.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
2.0 | 4.1 | GO:0034707 | chloride channel complex(GO:0034707) |
2.0 | 16.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.0 | 50.7 | GO:0014704 | intercalated disc(GO:0014704) |
2.0 | 36.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.0 | 27.9 | GO:0043196 | varicosity(GO:0043196) |
2.0 | 6.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
2.0 | 5.9 | GO:0048179 | activin receptor complex(GO:0048179) |
1.9 | 15.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.9 | 15.4 | GO:0036157 | outer dynein arm(GO:0036157) |
1.9 | 9.5 | GO:0044194 | cytolytic granule(GO:0044194) |
1.9 | 13.2 | GO:0044327 | dendritic spine head(GO:0044327) |
1.9 | 28.2 | GO:0046930 | pore complex(GO:0046930) |
1.9 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.8 | 3.7 | GO:0000776 | kinetochore(GO:0000776) |
1.8 | 105.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.8 | 5.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.8 | 21.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.8 | 3.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.8 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.8 | 73.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.7 | 8.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.7 | 36.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.7 | 3.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.7 | 22.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.7 | 3.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.7 | 11.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.7 | 5.0 | GO:0005712 | chiasma(GO:0005712) |
1.7 | 25.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.7 | 21.5 | GO:0043218 | compact myelin(GO:0043218) |
1.6 | 56.3 | GO:0032587 | ruffle membrane(GO:0032587) |
1.6 | 4.8 | GO:1990357 | terminal web(GO:1990357) |
1.6 | 11.2 | GO:0042581 | specific granule(GO:0042581) |
1.6 | 9.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.6 | 1.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.6 | 37.4 | GO:0016235 | aggresome(GO:0016235) |
1.6 | 10.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.6 | 7.8 | GO:0033270 | paranode region of axon(GO:0033270) |
1.6 | 1.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.5 | 44.7 | GO:0031519 | PcG protein complex(GO:0031519) |
1.5 | 16.8 | GO:0033391 | chromatoid body(GO:0033391) |
1.5 | 13.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
1.5 | 4.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.5 | 1.5 | GO:0034704 | calcium channel complex(GO:0034704) |
1.5 | 1.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 23.9 | GO:0051233 | spindle midzone(GO:0051233) |
1.5 | 6.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.5 | 68.6 | GO:0005912 | adherens junction(GO:0005912) |
1.5 | 5.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 7.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.4 | 17.4 | GO:0030057 | desmosome(GO:0030057) |
1.4 | 14.5 | GO:0031932 | TORC2 complex(GO:0031932) |
1.4 | 17.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.4 | 99.3 | GO:0043292 | contractile fiber(GO:0043292) |
1.4 | 4.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.4 | 1.4 | GO:1903349 | omegasome membrane(GO:1903349) |
1.4 | 2.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.4 | 1.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 1.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.4 | 18.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.4 | 1.4 | GO:1990696 | USH2 complex(GO:1990696) |
1.4 | 6.9 | GO:0071547 | piP-body(GO:0071547) |
1.4 | 12.2 | GO:0034706 | sodium channel complex(GO:0034706) |
1.3 | 5.4 | GO:0044292 | dendrite terminus(GO:0044292) |
1.3 | 13.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.3 | 12.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 5.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 39.9 | GO:0005581 | collagen trimer(GO:0005581) |
1.3 | 34.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.3 | 8.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.3 | 14.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.3 | 10.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.3 | 6.6 | GO:0005683 | U7 snRNP(GO:0005683) |
1.3 | 1.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.3 | 9.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.3 | 1.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 5.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.3 | 25.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.3 | 54.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
1.3 | 3.9 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
1.3 | 67.0 | GO:0042383 | sarcolemma(GO:0042383) |
1.3 | 3.8 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 25.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.3 | 8.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.3 | 152.2 | GO:0005769 | early endosome(GO:0005769) |
1.3 | 12.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
1.3 | 25.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.2 | 90.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
1.2 | 3.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.2 | 4.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 43.6 | GO:0045095 | keratin filament(GO:0045095) |
1.2 | 3.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 6.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.2 | 2.4 | GO:0043296 | apical junction complex(GO:0043296) |
1.2 | 3.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.2 | 1.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.2 | 3.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.2 | 16.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.2 | 10.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 4.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 133.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
1.2 | 10.6 | GO:0005869 | dynactin complex(GO:0005869) |
1.2 | 3.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.2 | 2.3 | GO:0042583 | chromaffin granule(GO:0042583) |
1.2 | 3.5 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 3.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.1 | 12.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 2.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.1 | 23.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.1 | 7.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 7.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.1 | 383.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
1.1 | 5.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.1 | 3.3 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 4.4 | GO:0045177 | apical part of cell(GO:0045177) |
1.1 | 29.6 | GO:0005884 | actin filament(GO:0005884) |
1.1 | 13.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.1 | 65.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.1 | 7.6 | GO:0016580 | Sin3 complex(GO:0016580) |
1.1 | 2.2 | GO:0035838 | growing cell tip(GO:0035838) |
1.1 | 34.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.1 | 19.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.1 | 15.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.1 | 24.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.1 | 201.0 | GO:0005667 | transcription factor complex(GO:0005667) |
1.0 | 7.3 | GO:0031902 | late endosome membrane(GO:0031902) |
1.0 | 5.2 | GO:0097255 | R2TP complex(GO:0097255) |
1.0 | 5.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.0 | 3.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.0 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.0 | 1.0 | GO:0016234 | inclusion body(GO:0016234) |
1.0 | 2.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.0 | 2.0 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 2.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 2.0 | GO:0097413 | Lewy body(GO:0097413) |
1.0 | 2.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 2.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.0 | 2.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 5.8 | GO:0030904 | retromer complex(GO:0030904) |
1.0 | 6.8 | GO:0031045 | dense core granule(GO:0031045) |
1.0 | 5.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 1.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.0 | 1.9 | GO:0000974 | Prp19 complex(GO:0000974) |
1.0 | 29.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.9 | 10.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.9 | 2.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 2.8 | GO:0016589 | NURF complex(GO:0016589) |
0.9 | 6.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 10.1 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 2.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.9 | 10.0 | GO:0032039 | integrator complex(GO:0032039) |
0.9 | 3.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 5.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.9 | 2.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 4.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 1.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 2.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.9 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 2.6 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 6.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.9 | 1.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.8 | 11.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.8 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.8 | 4.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 23.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 4.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.8 | 9.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.8 | 1.6 | GO:0000785 | chromatin(GO:0000785) |
0.8 | 2.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 2.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.8 | 5.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 2.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.8 | 5.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 4.8 | GO:0032009 | early phagosome(GO:0032009) |
0.8 | 0.8 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.8 | 3.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.8 | 65.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.8 | 6.2 | GO:0001726 | ruffle(GO:0001726) |
0.8 | 17.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.8 | 339.3 | GO:0009986 | cell surface(GO:0009986) |
0.8 | 75.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.8 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 7.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.8 | 5.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 5.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 1.5 | GO:0071546 | pi-body(GO:0071546) |
0.7 | 11.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 7.3 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.7 | 62.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.7 | 19.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.7 | 6.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.7 | 11.6 | GO:0045202 | synapse(GO:0045202) |
0.7 | 1.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 3.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 2.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 21.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.7 | 3.5 | GO:0090543 | Flemming body(GO:0090543) |
0.7 | 2.1 | GO:0071942 | XPC complex(GO:0071942) |
0.7 | 2.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.7 | 26.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.7 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.7 | 12.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.7 | 6.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.7 | 37.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 2.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 1.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 10.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.7 | 36.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 4.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 26.3 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 2.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.7 | 2.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 7.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.7 | 4.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 13.9 | GO:0031982 | vesicle(GO:0031982) |
0.7 | 2.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 25.7 | GO:0005929 | cilium(GO:0005929) |
0.7 | 2.6 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 1.3 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 1.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 2.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 3.2 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 2.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.6 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 1.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 34.2 | GO:0043235 | receptor complex(GO:0043235) |
0.6 | 22.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.6 | 15.7 | GO:0005844 | polysome(GO:0005844) |
0.6 | 4.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 6.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.6 | 7.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 160.1 | GO:0030054 | cell junction(GO:0030054) |
0.6 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 3.5 | GO:0044298 | cell body membrane(GO:0044298) |
0.6 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.6 | 5.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.6 | 4.0 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.6 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.6 | 7.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.6 | 5.6 | GO:0030425 | dendrite(GO:0030425) |
0.6 | 3.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.6 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.6 | 14.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.5 | 3.8 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 8.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 7.5 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 9.6 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 3.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 20.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 1.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.5 | 3.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 34.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.5 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 4.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.5 | 5.0 | GO:0005903 | brush border(GO:0005903) |
0.5 | 5.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 23.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 22.5 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.5 | 12.2 | GO:0005770 | late endosome(GO:0005770) |
0.5 | 3.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 1.4 | GO:0044447 | axoneme part(GO:0044447) |
0.5 | 46.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 1.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 1.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 7.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 18.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 7.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 4.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.5 | 3.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 1.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 1.8 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 4.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 5.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.4 | 91.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.4 | 17.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 16.8 | GO:0072372 | primary cilium(GO:0072372) |
0.4 | 8.8 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.4 | 38.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.4 | 10.0 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 5.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 33.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 230.7 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.4 | 1.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 22.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 9.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 6.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.4 | 309.8 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 721.1 | GO:0005886 | plasma membrane(GO:0005886) |
0.4 | 20.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 142.7 | GO:0005576 | extracellular region(GO:0005576) |
0.4 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 0.4 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.4 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 2.2 | GO:0005694 | chromosome(GO:0005694) |
0.4 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 1.1 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1193.2 | GO:0005634 | nucleus(GO:0005634) |
0.3 | 9.6 | GO:0032991 | macromolecular complex(GO:0032991) |
0.3 | 3.6 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.3 | 36.4 | GO:0005856 | cytoskeleton(GO:0005856) |
0.3 | 145.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 367.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 0.8 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 355.4 | GO:0016020 | membrane(GO:0016020) |
0.2 | 10.5 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 0.1 | GO:0043025 | neuronal cell body(GO:0043025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.3 | 39.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
12.3 | 36.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
11.9 | 35.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
11.2 | 67.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
10.9 | 54.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
10.9 | 43.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
10.8 | 32.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
9.5 | 47.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
9.5 | 104.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
9.4 | 46.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
8.7 | 26.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
8.4 | 58.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
8.4 | 8.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
8.2 | 24.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
8.1 | 56.9 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
7.6 | 30.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
7.3 | 72.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
7.2 | 28.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
6.8 | 40.7 | GO:0043426 | MRF binding(GO:0043426) |
6.5 | 78.2 | GO:0044548 | S100 protein binding(GO:0044548) |
6.4 | 38.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
6.3 | 25.1 | GO:0031014 | troponin T binding(GO:0031014) |
6.1 | 6.1 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
6.1 | 24.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
6.0 | 17.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
5.9 | 17.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
5.9 | 47.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
5.9 | 17.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
5.5 | 27.3 | GO:0030274 | LIM domain binding(GO:0030274) |
5.4 | 16.3 | GO:0055100 | adiponectin binding(GO:0055100) |
5.4 | 16.2 | GO:2001070 | starch binding(GO:2001070) |
5.3 | 116.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
5.3 | 26.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.2 | 62.7 | GO:0017166 | vinculin binding(GO:0017166) |
5.2 | 15.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
5.2 | 10.4 | GO:0030172 | troponin C binding(GO:0030172) |
5.2 | 46.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
5.1 | 15.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.0 | 30.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
5.0 | 15.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
4.9 | 9.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
4.9 | 24.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
4.9 | 19.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
4.9 | 39.0 | GO:0031432 | titin binding(GO:0031432) |
4.8 | 77.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
4.8 | 33.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
4.7 | 23.5 | GO:0070728 | leucine binding(GO:0070728) |
4.7 | 32.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
4.7 | 14.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
4.6 | 18.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
4.6 | 32.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
4.5 | 18.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
4.5 | 18.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
4.4 | 13.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
4.4 | 4.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
4.3 | 17.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
4.3 | 21.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.3 | 17.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
4.2 | 16.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
4.2 | 16.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
4.2 | 4.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
4.1 | 12.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
4.1 | 16.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
3.9 | 27.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
3.9 | 11.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.8 | 11.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
3.8 | 7.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
3.8 | 30.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
3.8 | 15.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
3.8 | 37.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.8 | 33.9 | GO:0031005 | filamin binding(GO:0031005) |
3.8 | 7.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.8 | 11.3 | GO:0048030 | disaccharide binding(GO:0048030) |
3.7 | 25.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
3.7 | 250.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
3.7 | 3.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
3.6 | 10.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.6 | 10.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
3.6 | 17.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.6 | 3.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
3.6 | 14.2 | GO:0043515 | kinetochore binding(GO:0043515) |
3.5 | 10.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
3.5 | 17.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.5 | 7.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
3.5 | 69.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
3.5 | 13.9 | GO:0042731 | PH domain binding(GO:0042731) |
3.5 | 6.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
3.5 | 48.3 | GO:0030955 | potassium ion binding(GO:0030955) |
3.4 | 37.3 | GO:0005522 | profilin binding(GO:0005522) |
3.3 | 29.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.3 | 9.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.3 | 9.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.2 | 6.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
3.2 | 3.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.2 | 16.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
3.2 | 12.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.2 | 9.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.2 | 15.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.1 | 24.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.1 | 30.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.1 | 3.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
3.1 | 6.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
3.1 | 18.4 | GO:0015288 | porin activity(GO:0015288) |
3.1 | 27.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
3.0 | 70.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
3.0 | 15.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.0 | 91.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
3.0 | 24.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
3.0 | 53.9 | GO:0005112 | Notch binding(GO:0005112) |
3.0 | 14.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.9 | 8.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.9 | 17.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
2.9 | 11.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.9 | 8.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.9 | 2.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
2.9 | 226.7 | GO:0005178 | integrin binding(GO:0005178) |
2.9 | 8.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.8 | 5.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.8 | 19.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
2.8 | 16.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
2.8 | 30.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.8 | 5.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.8 | 13.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.7 | 2.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.7 | 51.7 | GO:0043236 | laminin binding(GO:0043236) |
2.7 | 10.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.7 | 13.4 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
2.7 | 8.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.6 | 29.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.6 | 7.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.6 | 5.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.5 | 15.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.5 | 58.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
2.5 | 5.1 | GO:0070402 | NADPH binding(GO:0070402) |
2.5 | 17.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.5 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
2.5 | 7.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.4 | 4.9 | GO:0050692 | DBD domain binding(GO:0050692) |
2.4 | 17.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
2.4 | 12.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.4 | 4.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
2.4 | 14.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.4 | 21.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.4 | 2.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.4 | 9.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
2.4 | 9.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
2.4 | 21.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.3 | 7.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
2.3 | 11.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
2.3 | 7.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.3 | 6.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.3 | 4.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.3 | 2.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.3 | 41.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.3 | 4.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.3 | 9.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
2.3 | 66.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.3 | 9.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
2.3 | 20.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.3 | 13.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.2 | 24.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.2 | 4.5 | GO:0030519 | snoRNP binding(GO:0030519) |
2.2 | 9.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.2 | 17.8 | GO:0038191 | neuropilin binding(GO:0038191) |
2.2 | 11.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.2 | 20.0 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
2.2 | 2.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.2 | 17.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.2 | 11.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.2 | 2.2 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
2.2 | 6.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.2 | 10.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.2 | 15.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
2.2 | 4.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
2.1 | 10.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
2.1 | 6.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
2.1 | 6.3 | GO:0070513 | death domain binding(GO:0070513) |
2.1 | 8.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.1 | 8.3 | GO:0030911 | TPR domain binding(GO:0030911) |
2.1 | 6.2 | GO:0035473 | lipase binding(GO:0035473) |
2.1 | 12.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.1 | 10.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.1 | 2.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
2.1 | 26.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
2.0 | 8.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.0 | 28.6 | GO:0005542 | folic acid binding(GO:0005542) |
2.0 | 20.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.0 | 4.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.0 | 6.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.0 | 24.3 | GO:0042805 | actinin binding(GO:0042805) |
2.0 | 8.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.0 | 8.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.0 | 24.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
2.0 | 4.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.0 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.0 | 27.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
2.0 | 6.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.0 | 7.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.0 | 184.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
2.0 | 609.6 | GO:0003779 | actin binding(GO:0003779) |
2.0 | 7.9 | GO:0045545 | syndecan binding(GO:0045545) |
2.0 | 5.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.0 | 9.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.0 | 11.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.0 | 60.6 | GO:0005109 | frizzled binding(GO:0005109) |
1.9 | 5.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.9 | 5.8 | GO:0030984 | kininogen binding(GO:0030984) |
1.9 | 5.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.9 | 11.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.9 | 3.8 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
1.9 | 16.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.9 | 3.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.9 | 3.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.8 | 14.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.8 | 9.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.8 | 10.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.8 | 1.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.8 | 10.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.8 | 7.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.8 | 7.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.8 | 5.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.8 | 5.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.8 | 10.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.8 | 3.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 42.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.8 | 10.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.8 | 28.1 | GO:0030552 | cAMP binding(GO:0030552) |
1.8 | 3.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 7.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.7 | 7.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.7 | 3.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.7 | 23.9 | GO:0008143 | poly(A) binding(GO:0008143) |
1.7 | 25.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.7 | 6.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.7 | 11.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.7 | 3.4 | GO:0034714 | type II transforming growth factor beta receptor binding(GO:0005114) type III transforming growth factor beta receptor binding(GO:0034714) |
1.7 | 3.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.7 | 8.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.7 | 5.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.7 | 8.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.7 | 8.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.7 | 21.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.7 | 1.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
1.6 | 3.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.6 | 4.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.6 | 27.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.6 | 6.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.6 | 38.8 | GO:0005518 | collagen binding(GO:0005518) |
1.6 | 1.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.6 | 1.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.6 | 8.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.6 | 11.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.6 | 3.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.6 | 15.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.6 | 6.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.6 | 11.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.6 | 4.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.6 | 7.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.6 | 11.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.6 | 1.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.6 | 9.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.6 | 4.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.6 | 21.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.6 | 1.6 | GO:0031402 | sodium ion binding(GO:0031402) |
1.6 | 3.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 6.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.5 | 4.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.5 | 1.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.5 | 6.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.5 | 1.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.5 | 15.2 | GO:0051378 | serotonin binding(GO:0051378) |
1.5 | 1.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
1.5 | 24.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.5 | 45.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.5 | 33.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.5 | 4.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.5 | 9.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.5 | 7.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.5 | 139.5 | GO:0008201 | heparin binding(GO:0008201) |
1.5 | 5.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.5 | 20.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.5 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.5 | 5.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.5 | 17.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.5 | 2.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.5 | 4.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.5 | 7.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.4 | 14.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
1.4 | 1.4 | GO:0035197 | siRNA binding(GO:0035197) |
1.4 | 24.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.4 | 5.7 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.4 | 4.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.4 | 2.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.4 | 4.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 46.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.4 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.4 | 5.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.4 | 4.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.4 | 5.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.4 | 4.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.4 | 5.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.4 | 2.8 | GO:0004096 | catalase activity(GO:0004096) |
1.4 | 14.0 | GO:0030507 | spectrin binding(GO:0030507) |
1.4 | 5.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.4 | 5.6 | GO:0048185 | activin binding(GO:0048185) |
1.4 | 4.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.4 | 9.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.4 | 1.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.4 | 12.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.4 | 48.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.4 | 1.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.4 | 5.5 | GO:0050733 | RS domain binding(GO:0050733) |
1.4 | 4.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.4 | 48.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.4 | 4.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.4 | 5.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.4 | 5.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 2.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.4 | 12.2 | GO:0034793 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.4 | 12.2 | GO:0003796 | lysozyme activity(GO:0003796) |
1.4 | 14.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.4 | 9.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.4 | 4.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.4 | 5.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.3 | 4.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.3 | 14.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.3 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 5.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.3 | 2.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.3 | 17.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.3 | 12.0 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
1.3 | 13.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.3 | 1.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.3 | 14.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.3 | 5.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.3 | 4.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 5.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.3 | 9.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.3 | 3.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 6.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.3 | 10.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.3 | 23.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.3 | 2.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.3 | 9.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.3 | 68.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
1.3 | 2.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.3 | 2.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.3 | 18.0 | GO:0015026 | coreceptor activity(GO:0015026) |
1.3 | 8.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 8.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.3 | 6.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.3 | 43.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.3 | 26.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 5.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.3 | 5.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.3 | 3.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 8.8 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
1.2 | 5.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.2 | 5.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.2 | 3.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.2 | 1.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.2 | 2.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.2 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.2 | 3.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.2 | 6.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.2 | 6.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.2 | 9.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.2 | 3.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 217.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
1.2 | 19.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.2 | 3.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.2 | 14.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
1.2 | 2.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
1.2 | 33.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
1.2 | 3.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 9.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.2 | 2.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.2 | 2.4 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 7.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.2 | 6.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.2 | 5.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 26.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.2 | 13.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.2 | 5.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.2 | 2.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.2 | 1.2 | GO:0070403 | NAD+ binding(GO:0070403) |
1.2 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 3.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.2 | 4.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.2 | 2.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.2 | 4.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
1.2 | 2.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.1 | 4.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.1 | 11.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.1 | 1.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.1 | 4.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.1 | 15.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 5.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.1 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.1 | 31.4 | GO:0019894 | kinesin binding(GO:0019894) |
1.1 | 6.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.1 | 6.7 | GO:0046790 | virion binding(GO:0046790) |
1.1 | 7.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.1 | 5.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.1 | 4.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.1 | 3.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.1 | 3.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.1 | 2.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 2.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.1 | 2.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.1 | 1.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.1 | 2.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.1 | 1.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.1 | 7.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.1 | 222.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
1.1 | 5.3 | GO:0050700 | CARD domain binding(GO:0050700) |
1.1 | 10.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.1 | 22.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 20.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 2.1 | GO:0010853 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
1.1 | 2.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 3.2 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 17.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
1.0 | 3.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.0 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
1.0 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.0 | 15.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.0 | 3.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.0 | 6.2 | GO:0030546 | receptor activator activity(GO:0030546) |
1.0 | 5.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 11.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 2.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.0 | 5.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 3.1 | GO:0016015 | morphogen activity(GO:0016015) |
1.0 | 26.6 | GO:0015485 | cholesterol binding(GO:0015485) |
1.0 | 57.2 | GO:0005262 | calcium channel activity(GO:0005262) |
1.0 | 13.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.0 | 13.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.0 | 1.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.0 | 3.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.0 | 9.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 4.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 10.1 | GO:0005521 | lamin binding(GO:0005521) |
1.0 | 35.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
1.0 | 7.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.0 | 1.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.0 | 12.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 12.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.0 | 4.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 3.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.0 | 5.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.0 | 28.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.0 | 20.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
1.0 | 4.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.0 | 5.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.0 | 10.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.0 | 2.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 30.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
1.0 | 2.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.0 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.0 | 23.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.0 | 24.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
1.0 | 2.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.0 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.0 | 1.9 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 1.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.0 | 1.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
1.0 | 3.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.0 | 3.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.0 | 17.2 | GO:0005272 | sodium channel activity(GO:0005272) |
1.0 | 3.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
1.0 | 8.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.9 | 12.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.9 | 7.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.9 | 1.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 10.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 0.9 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.9 | 2.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.9 | 3.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.9 | 4.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.9 | 3.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.9 | 9.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 3.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.9 | 0.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.9 | 29.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.9 | 2.7 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.9 | 3.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.9 | 9.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.9 | 5.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 3.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 20.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.9 | 5.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.9 | 2.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.9 | 17.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.9 | 2.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 8.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 1.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.9 | 11.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 2.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.9 | 2.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.9 | 2.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.9 | 1.7 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 2.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.9 | 3.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.9 | 5.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.8 | 69.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.8 | 1.7 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.8 | 2.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 4.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.8 | 2.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.8 | 3.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 4.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 7.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.8 | 2.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 3.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 1.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 4.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.8 | 2.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.8 | 10.6 | GO:0017022 | myosin binding(GO:0017022) |
0.8 | 45.2 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.8 | 2.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 14.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.8 | 31.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.8 | 232.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.8 | 1.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 3.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 5.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 3.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.8 | 1.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.8 | 30.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.8 | 5.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.8 | 43.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.8 | 13.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.8 | 1.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 14.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.8 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.8 | 15.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.8 | 10.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.8 | 3.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 36.4 | GO:0019003 | GDP binding(GO:0019003) |
0.8 | 0.8 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.8 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 2.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 14.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.7 | 6.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.7 | 2.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.7 | 39.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.7 | 1.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.7 | 0.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.7 | 2.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.7 | 17.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 14.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.7 | 3.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.7 | 4.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.7 | 2.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 2.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.7 | 2.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.7 | 31.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.7 | 1.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 24.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.7 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 5.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 5.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.7 | 8.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.7 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.7 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 18.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.7 | 7.4 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.7 | 0.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 4.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 6.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.7 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.7 | 8.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.7 | 21.3 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.7 | 8.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.7 | 2.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.7 | 1.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.7 | 7.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 3.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 26.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.6 | 9.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 3.2 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.6 | 3.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.6 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.6 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 1.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.6 | 10.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 1.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.6 | 1.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.6 | 6.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 5.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.6 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 6.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 1.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 1.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 1.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.6 | 8.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 6.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.6 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 3.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.6 | 39.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.6 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 4.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 3.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 1.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 1.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.6 | 2.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 6.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 6.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 1.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 1.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.6 | 17.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.6 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 4.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 43.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 0.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 8.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 2.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 9.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.6 | 4.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.6 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 49.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.6 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 1.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.6 | 3.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 1.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.6 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.5 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 5.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 3.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.5 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.5 | 2.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.5 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.5 | 33.7 | GO:0015293 | symporter activity(GO:0015293) |
0.5 | 2.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 61.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 2.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 46.1 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 1.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 1.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.5 | 17.2 | GO:0018727 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.5 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 1.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.5 | 2.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.5 | 4.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 1.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 7.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.5 | 44.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.5 | 14.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 2.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 1.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 6.5 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.5 | 4.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 6.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 3.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 4.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 3.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.6 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.4 | 9.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.4 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 4.8 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.4 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 5.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 5.6 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 1.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 6.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 5.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 1.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 1.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.3 | GO:0042562 | hormone binding(GO:0042562) |
0.4 | 3.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 2.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 5.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 4.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 13.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 6.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 8.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 20.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 2.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 2.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.4 | 10.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.4 | 3.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.4 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 1.9 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) phospholipase C activity(GO:0004629) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 13.5 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 49.7 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.4 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 1.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.4 | 4.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 10.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 103.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.4 | 4.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 2.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 8.0 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.4 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 5.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.8 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.4 | 21.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.4 | 8.2 | GO:0016853 | isomerase activity(GO:0016853) |
0.4 | 6.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 10.0 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 12.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 22.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 4.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 9.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 14.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 31.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 69.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.3 | 104.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 3.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 12.5 | GO:0005261 | cation channel activity(GO:0005261) |
0.3 | 1.9 | GO:0097617 | annealing activity(GO:0097617) |
0.3 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 41.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 2.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 257.3 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 1.2 | GO:0034416 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 12.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 2.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 5.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 6.9 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.3 | 8.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 3.0 | GO:0015291 | secondary active transmembrane transporter activity(GO:0015291) |
0.3 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 5.5 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 2.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 0.9 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
0.2 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.6 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 4.7 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 2.0 | GO:0008875 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.2 | 0.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 0.5 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 10.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.2 | 84.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 23.8 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 1.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 3.1 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.8 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 2.6 | GO:0033218 | amide binding(GO:0033218) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 2.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 3.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 3.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 2.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.8 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 103.6 | GO:0005515 | protein binding(GO:0005515) |
0.1 | 9.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 7.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 6.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 10.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
6.3 | 94.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.9 | 53.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.8 | 125.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
4.7 | 14.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
4.6 | 4.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
4.5 | 31.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
4.4 | 100.7 | PID ALK1 PATHWAY | ALK1 signaling events |
4.0 | 172.6 | NABA COLLAGENS | Genes encoding collagen proteins |
3.9 | 55.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
3.9 | 88.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
3.8 | 167.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
3.7 | 88.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
3.5 | 97.2 | PID RAS PATHWAY | Regulation of Ras family activation |
3.4 | 16.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
3.3 | 140.8 | PID FGF PATHWAY | FGF signaling pathway |
3.2 | 87.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
3.2 | 54.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
3.1 | 46.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.9 | 40.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.8 | 30.7 | PID IGF1 PATHWAY | IGF1 pathway |
2.8 | 24.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
2.7 | 73.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
2.5 | 72.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.5 | 46.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
2.4 | 48.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
2.4 | 24.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
2.4 | 19.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
2.3 | 35.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.3 | 364.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
2.3 | 15.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
2.2 | 35.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.2 | 29.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.2 | 54.9 | PID BMP PATHWAY | BMP receptor signaling |
2.2 | 6.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.2 | 63.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.1 | 6.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.1 | 77.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
2.1 | 4.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.1 | 29.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.1 | 57.7 | PID AURORA B PATHWAY | Aurora B signaling |
2.0 | 34.7 | PID AURORA A PATHWAY | Aurora A signaling |
2.0 | 12.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.0 | 30.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.9 | 261.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.9 | 391.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.9 | 46.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.9 | 71.3 | PID ENDOTHELIN PATHWAY | Endothelins |
1.9 | 11.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.8 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.8 | 11.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.8 | 27.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.8 | 7.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.8 | 36.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.7 | 6.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.7 | 37.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.7 | 83.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.7 | 13.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.7 | 14.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.6 | 14.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.5 | 325.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
1.5 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
1.5 | 45.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.5 | 4.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.5 | 5.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 16.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.5 | 23.3 | PID RHOA PATHWAY | RhoA signaling pathway |
1.4 | 13.0 | PID SHP2 PATHWAY | SHP2 signaling |
1.4 | 31.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.4 | 8.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.4 | 1.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.4 | 5.6 | PID IFNG PATHWAY | IFN-gamma pathway |
1.4 | 9.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.3 | 26.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.3 | 17.2 | PID ARF6 PATHWAY | Arf6 signaling events |
1.3 | 9.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.3 | 17.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.3 | 23.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.3 | 9.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.3 | 5.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.2 | 18.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.2 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.2 | 4.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.2 | 3.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.2 | 38.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.2 | 7.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.1 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.1 | 14.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.1 | 9.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 4.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.1 | 6.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.1 | 16.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.0 | 29.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.0 | 12.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.0 | 28.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.0 | 20.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.0 | 6.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.0 | 1.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.0 | 16.3 | PID LKB1 PATHWAY | LKB1 signaling events |
1.0 | 7.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.9 | 8.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.9 | 9.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.9 | 4.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.9 | 7.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 9.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.8 | 10.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 3.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.8 | 1.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 28.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 6.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 4.3 | PID FOXO PATHWAY | FoxO family signaling |
0.7 | 6.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 3.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 8.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.6 | 3.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 10.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.6 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 2.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 7.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 4.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 5.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 13.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 12.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 11.8 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 12.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 2.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 3.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 10.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 3.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 7.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 20.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 5.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 5.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 1.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 2.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 3.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 7.6 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 104.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
7.7 | 91.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
6.3 | 138.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
6.2 | 93.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
4.7 | 109.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
4.3 | 59.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
4.1 | 89.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
4.0 | 35.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
3.8 | 82.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.7 | 11.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
3.6 | 32.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
3.6 | 32.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.6 | 192.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
3.4 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
3.4 | 47.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.3 | 136.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
3.3 | 26.1 | REACTOME OPSINS | Genes involved in Opsins |
3.2 | 6.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
3.1 | 15.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.7 | 13.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
2.6 | 44.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.5 | 32.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.5 | 42.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.5 | 27.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
2.4 | 36.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
2.4 | 21.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.3 | 48.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.3 | 25.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.3 | 29.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.2 | 4.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.2 | 19.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.2 | 21.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.2 | 39.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
2.2 | 23.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
2.2 | 21.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.1 | 49.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
2.1 | 27.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.1 | 33.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.1 | 16.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.0 | 22.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
2.0 | 132.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
2.0 | 17.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.9 | 17.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.9 | 44.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.9 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.9 | 9.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.9 | 18.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.8 | 27.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.8 | 27.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
1.8 | 49.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.8 | 40.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.8 | 14.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.8 | 30.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.7 | 18.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.7 | 18.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.7 | 47.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.7 | 45.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.7 | 1.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.7 | 18.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.6 | 3.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
1.6 | 17.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.6 | 11.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
1.6 | 15.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.5 | 28.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.5 | 5.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.5 | 16.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.4 | 33.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
1.4 | 8.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.4 | 14.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.4 | 11.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.4 | 27.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 27.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.4 | 12.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 18.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.4 | 11.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.4 | 9.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.3 | 29.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.3 | 13.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.3 | 11.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 13.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.3 | 37.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.3 | 6.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.3 | 5.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 19.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.3 | 32.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.3 | 5.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.3 | 39.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.2 | 3.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.2 | 13.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.2 | 19.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.2 | 7.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.2 | 7.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.2 | 17.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.2 | 4.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.2 | 10.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.2 | 9.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
1.2 | 11.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.1 | 36.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
1.1 | 48.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
1.1 | 4.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.1 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.1 | 4.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.1 | 19.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.1 | 6.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.1 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 11.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.0 | 44.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 2.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
1.0 | 1.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.0 | 9.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 7.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.0 | 42.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.0 | 14.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.0 | 66.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.0 | 14.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.0 | 8.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.0 | 44.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.0 | 7.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.0 | 7.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 24.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 20.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 26.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.9 | 11.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.9 | 2.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 65.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.9 | 19.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.9 | 11.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.9 | 8.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.9 | 4.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 3.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.9 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.9 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.8 | 68.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.8 | 0.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.8 | 5.8 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.8 | 26.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.8 | 22.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 87.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 6.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.8 | 5.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.8 | 13.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.8 | 6.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.8 | 3.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.8 | 1.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 10.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.7 | 20.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.7 | 15.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 5.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 7.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 27.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.7 | 28.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.7 | 16.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.7 | 0.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 6.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.7 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.7 | 2.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 15.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 6.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 11.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 6.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.6 | 4.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 1.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 6.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 5.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.6 | 1.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 6.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 64.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 2.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.5 | 36.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 34.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 1.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 3.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 7.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 1.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 13.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 6.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 27.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 10.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 8.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.4 | 7.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 7.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 7.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 14.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 5.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 2.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 1.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 5.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 8.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 4.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 3.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 6.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 4.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 10.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 0.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.4 | 1.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 5.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.4 | 3.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 4.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 6.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 39.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 18.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 12.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 5.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 6.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 2.1 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.3 | 8.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 6.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 4.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 6.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 0.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.8 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.0 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |